Developing a Core Outcome Set for Netherton Syndrome: An International Multi-Stakeholder e-Delphi Consensus Study制定Netherton综合征的核心结果集: 一项国际多利益相关方e-delphi共识研究DERMATOLOGYIF2.72024-11-010OA
Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22024-11-011OAAI
Polysaccharide, Conjugate, and mRNA-based Vaccines are Immunogenic in Patients with Netherton SyndromeJOURNAL OF CLINICAL IMMUNOLOGYIF5.72024-10-300OAAI
Treatment Experiences with Intravenous Immunoglobulins, Ixekizumab, Dupilumab, and Anakinra in Netherton Syndrome: A Case SeriesDERMATOLOGYIF2.72022-08-2314OA
Outcomes of Systemic Treatment in Children and Adults With Netherton Syndrome: A Systematic ReviewFRONTIERS IN IMMUNOLOGYIF5.92022-03-3015OAAI
Natural moisturizing factor as a biomarker for filaggrin mutation status in a multi-ethnic paediatric atopic dermatitis cohortCLINICAL AND EXPERIMENTAL ALLERGYIF5.22021-08-288OAAI